More Post from the Author
- AutoMobility LA 2025
- Radiate Holdco, LLC Releases Third Quarter 2025 Financial Results
- Workshop Debuts Four New AI Features, Positioning Itself as the Clear Leader in AI for Internal Communications
- r4 Technologies Donates Smart Food AI Program to Help States Feed SNAP Beneficiaries
- Armor Health's Data Driven Approach to Patient Care Helps Secure Agreement to Provide Correctional Healthcare Service for Inmates in Bell County Texas
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC
Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- AutoMobility LA 2025
- Radiate Holdco, LLC Releases Third Quarter 2025 Financial Results
- Workshop Debuts Four New AI Features, Positioning Itself as the Clear Leader in AI for Internal Communications
- r4 Technologies Donates Smart Food AI Program to Help States Feed SNAP Beneficiaries
- Armor Health's Data Driven Approach to Patient Care Helps Secure Agreement to Provide Correctional Healthcare Service for Inmates in Bell County Texas